Embolization beads are the most common agents used in interventional radiology to block blood vessels. They are used to reduce or prevent blood supply into vessels feeding a tumor (uterine fibroid, liver, kidney). Controlling their mechanical properties is essential, as the bead injection process and lodging within the vessel strongly depend upon them. We propose a standardized method to characterize the complete viscoelastic behavior of single embolization beads by combining a compression test to measure the bead elasticity with a relaxation test to measure the material viscosity. Those two parameters will be used as a gold standard in developing new embolization beads carrying drugs.
Two commercial agents are tested: polyethylene glycol beads (PG-beads) and Trisacryl Gelatin beads (TG-beads). For validation purposes, measurements are also conducted on alginate beads and compared with.
We show that the tested commercial agents present a linear elastic behavior up to at least 15% of deformation like the alginate beads, and that they have a Young modulus of the order of 5 kPa.
Contrary to the alginate beads that have negligible viscosity (51 /pm 18 kPa.s), the commercial beads exhibit viscoelasticity (viscosity of 1 560 /pm 0.34 kPa.s for the TG-beads and 690 /pm14 kPa.s for the PEG-beads).
The beads present on the market thus have similar elastic properties but present differ relaxation behaviour, which is likely to influence the bead injectability and sustainability of embolization in vivo.